Home
Conditions
Metabolic Dysfunction-Associated Steatotic Liver Disease

Clinical trial condition

Metabolic Dysfunction-Associated Steatotic Liver Disease

Explore clinical trials studying Metabolic Dysfunction-Associated Steatotic Liver Disease. Study availability and eligibility vary by location and protocol.

71 public trials 22 recruiting studies

Refine in advanced search Browse all conditions

Metabolic Dysfunction-Associated Steatotic Liver Disease trial results

Enrolling by invitation

Improving Diagnostic Safety Through STeatosis Identification, Risk Stratification, and Referral in the ED

NCT06944353

Conditions: Digestive System Diseases, Fatty Liver, Liver Diseases, +4 more
Locations: Northwestern Memorial Hospital Chicago, Illinois, United States

View Trial Details

Enrolling by invitation

Guerbet Liver Fibrosis

NCT06703450

Conditions: Metabolic Dysfunction-Associated Steatotic Liver Disease
Locations: Mount Sinai New York, United States

View Trial Details

Enrolling by invitation

Assessment of Non-Invasive Testing in Major Liver-Related Outcomes

NCT06986447

Conditions: MASLD, MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis), +2 more
Locations: Arizona Liver Health Chandler, Arizona, United States

Arizona Liver Health Peoria, Arizona, United States

Arizona Liver Health Tucson, Arizona, United States

CRIOH Westlake, Ohio, United States

View Trial Details

Enrolling by invitation

Effect on Body Weight Reduction of a Behavioral Intervention on Lifestyle Using a Digital Nutritional Program in People Living With HIV and Metabolic Dysfunction-associated Steatotic Liver Disease

NCT07456332

Conditions: Life Style, Metabolic Dysfunction-Associated Steatotic Liver Disease, People Living With HIV
Locations: Hospital Universitari de Bellvitge L'Hospitalet de Llobregat, Barcelona, Spain

View Trial Details

Enrolling by invitation

Metabolically Healthy Obesity Increases the Risks of MASLD and Hyperuricemia

NCT07001865

Conditions: Body Weight, Hyperuricemia, Metabolic Dysfunction-Associated Steatotic Liver Disease, +10 more
Locations: the First Affiliated Hospital of Ningbo University Ningbo, Zhejiang, China, 315000, Ningbo, Zhejiang Province 315000 Recruiting Ningbo, China

View Trial Details

Active, not recruiting

Developing Microbial Therapy for MASLD: From Mechanism to Clinical Validation

NCT07488975

Conditions: Metabolic Dysfunction-Associated Steatotic Liver Disease
Locations: National Taiwan University Hospital Taipei, Taiwan

View Trial Details

Active, not recruiting

Effect of a GnRH Analog on Hepatic Steatosis

NCT06523530

Conditions: Digestive System Diseases, Endometriosis, Fatty Liver, +13 more
Locations: 424 General Military Hospital Thessaloniki, Greece

1st Department of Obstetrics and Gynecology, School of Medicine, Aristotle University of Thessaloniki Thessaloniki, Greece

View Trial Details

Active, not recruiting

Effects of iGlarLixi Versus iGlar on Liver Fat Content in Patients With Type 2 Diabetes Mellitus Combined With Metabolic Dysfunction-associated Steatotic Liver Disease

NCT07274644

Conditions: Diabetes Mellitus, Diabetes Mellitus Type 2, Diabetes Mellitus, Type 2, +5 more
Locations: Department of Endocrinology, the Affiliated Drum Tower Hospital of Nanjing University Medical School Nanjing, Jiangsu, China

View Trial Details

Active, not recruiting

Influence of Metabolic Syndrome on Endogenous Oxalate Synthesis

NCT06735924

Conditions: MASLD, Metabolic Dysfunction-Associated Steatotic Liver Disease
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

View Trial Details

Completed

A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)

NCT06465186

Conditions: Digestive System Diseases, Fatty Liver, Liver Diseases, +6 more
Locations: The Institute for Liver Health II dba Arizona Clinical Trial-The Institute for Liver Health ( Site 0149) Chandler, Arizona, United States

Arizona Clinical Trials ( Site 0158) Flagstaff, Arizona, United States

The Institute for Liver Health II dba Arizona Liver Health - Peoria ( Site 0120) Peoria, Arizona, United States

The Institute for Liver Health II dba Arizona Liver Health-Tucson ( Site 0111) Tucson, Arizona, United States

View all 68 locations

View Trial Details

Metabolic Dysfunction-Associated Steatotic Liver Disease

Metabolic Dysfunction-Associated Steatotic Liver Disease trial results

Related conditions